Trash Talk

  • by: |
  • 02/20/2010

Maine lawmakers are debating a bill that would require pharmaceutical companies to retrieve unused prescription drugs from households across the state. The measure is designed to prevent those medicines from ending up in Maine’s water supply.

Protecting Maine’s drinking water is of paramount importance. But the bill won’t make Maine’s water any cleaner. And it could raise the price of medicines and stifle biopharmaceutical research.

(The bill is LD 821, “An Act to Support Collection and Proper Disposal of Unused Drugs”)

For starters, more than 90 percent of the drugs that find their way into tap water comes from the waste products of those who have ingested their medicines correctly — not from folks improperly flushing their meds down the toilet. So this “take back” program would do nothing to prevent the main source of pharmaceutical chemicals in water.

Moreover, the safest and most effective way to dispose of drugs is to toss them in the household trash, in sealed plastic bags to keep them away from children and pets. That waste is eventually held in secure landfills, preventing any chemicals from leaking into surface waters.

A secondary function of the bill, according to its supporters, is to get pharmaceuticals out of the hands of those who might abuse them.

Any legislation that takes the issue of drug abuse seriously, however, needs to provide communities with the resources to teach their citizens about the dangers of prescription drugs. This bill does not.

Even if the Maine Legislature went back to the drawing board and attempted to design a bill that actually improved residents’ health, lawmakers still would be hard-pressed to create effective regulations. That’s because water quality, by its very nature, isn’t a state issue — it’s a national issue.

The Mississippi River Watershed runs through 31 states. The Chesapeake Bay Watershed serves 17 million people in seven states plus the District of Columbia. There’s no doubt that water safety deserves serious attention from the government. And Maine lawmakers should do their best to ensure that the local water supply remains free of pollutants. But this bill would be ineffective at the state level.

The problems with this bill go beyond its inefficacy. It actually could jeopardize the health care of patients across the country.

Creating the complex and expansive network required to regularly collect unused drugs from resident homes would be a very costly enterprise. Consequently, this bill would dramatically drive up the operating costs for medical research firms, leaving less money for scientists to develop new drugs. That’s particularly bad news for those suffering from conditions like cancer and Parkinson’s, whose lives depend on future medical innovation.

What’s more, drug makers likely will try to recoup dollars lost on recovery programs by raising prices on their products. So folks would see higher pharmacy bills at a time of great economic instability.

Maine lawmakers have crafted a bill that fails to address the important issues of water purity and prescription drug abuse, and actually harms people’s health care.

They can do better.

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog